Kewaunee Scientific Corporation (KEQU): Price and Financial Metrics

KEQU Stock Summary

• KEWAUNEE SCIENTIFIC CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 91.39% of US listed stocks.
• Of note is the ratio of KEWAUNEE SCIENTIFIC CORP's sales and general administrative expense to its total operating expenses; 96.99% of US stocks have a lower such ratio.
• With a price/sales ratio of 0.26, KEWAUNEE SCIENTIFIC CORP has a higher such ratio than merely 7.32% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to KEWAUNEE SCIENTIFIC CORP, a group of peers worth examining would be ENG, OCC, HBB, ODP, and PFMT.
• KEQU's SEC filings can be seen here. And to visit KEWAUNEE SCIENTIFIC CORP's official web site, go to www.kewaunee.com.

KEQU Valuation Summary

• In comparison to the median Consumer Cyclical stock, KEQU's price/earnings ratio is 172.27% lower, now standing at -8.6.
• Over the past 243 months, KEQU's EV/EBIT ratio has gone down 75.3.

Below are key valuation metrics over time for KEQU.

KEQU Growth Metrics

Its 2 year net income to common stockholders growth rate is now at -30.7%.
• Its 5 year net income to common stockholders growth rate is now at -205%.
• Its 3 year cash and equivalents growth rate is now at -38.2%.

The table below shows KEQU's growth in key financial areas (numbers in millions of US dollars).